TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1)

PHASE3CompletedINTERVENTIONAL
Enrollment

679

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Migraine, Without Aura
Interventions
DRUG

sumatriptan succinate / naproxen sodium

sumatriptan 85mg / naproxen sodium 500mg

DRUG

Placebo

Placebo to match Treximet tablets

Trial Locations (70)

10022

GSK Investigational Site, New York

10461

GSK Investigational Site, The Bronx

11580

GSK Investigational Site, Valley Stream

12206

GSK Investigational Site, Albany

14642

GSK Investigational Site, Rochester

15106

GSK Investigational Site, Carnegie

15213

GSK Investigational Site, Pittsburgh

15236

GSK Investigational Site, Pittsburgh

22311

GSK Investigational Site, Alexandria

27401

GSK Investigational Site, Greensboro

27599

GSK Investigational Site, Chapel Hill

27609

GSK Investigational Site, Raleigh

29621

GSK Investigational Site, Anderson

29681

GSK Investigational Site, Simpsonville

30033

GSK Investigational Site, Atlanta

30308

GSK Investigational Site, Atlanta

30342

GSK Investigational Site, Atlanta

33024

GSK Investigational Site, Pembroke Pines

33407

GSK Investigational Site, West Palm Beach

37203

GSK Investigational Site, Nashville

43081

GSK Investigational Site, Westerville

44131

GSK Investigational Site, Independence

44195

GSK Investigational Site, Cleveland

45069

GSK Investigational Site, West Chester

45245

GSK Investigational Site, Cincinnati

47712

GSK Investigational Site, Evansville

48104

GSK Investigational Site, Ann Arbor

49009

GSK Investigational Site, Kalamazoo

55426

GSK Investigational Site, Saint Louis Park

60614

GSK Investigational Site, Chicago

63141

GSK Investigational Site, St Louis

65804

GSK Investigational Site, Springfield

67207

GSK Investigational Site, Wichita

70121

GSK Investigational Site, New Orleans

72205

GSK Investigational Site, Little Rock

75080

GSK Investigational Site, Richardson

77030

GSK Investigational Site, Houston

77401

GSK Investigational Site, Bellaire

77450

GSK Investigational Site, Katy

78229

GSK Investigational Site, San Antonio

78705

GSK Investigational Site, Austin

78745

GSK Investigational Site, Austin

80904

GSK Investigational Site, Colorado Springs

84084

GSK Investigational Site, West Jordan

84107

GSK Investigational Site, Salt Lake City

84109

GSK Investigational Site, Salt Lake City

84121

GSK Investigational Site, Salt Lake City

85014

GSK Investigational Site, Phoenix

85050

GSK Investigational Site, Phoenix

87108

GSK Investigational Site, Albuquerque

89146

GSK Investigational Site, Las Vegas

90404

GSK Investigational Site, Santa Monica

90620

GSK Investigational Site, Buena Park

91361

GSK Investigational Site, Westlake Village

91765

GSK Investigational Site, Diamond Bar

92128

GSK Investigational Site, San Diego

92660

GSK Investigational Site, Newport Beach

92801

GSK Investigational Site, Anaheim

92805

GSK Investigational Site, Anaheim

94109

GSK Investigational Site, San Francisco

94596

GSK Investigational Site, Walnut Creek

98104

GSK Investigational Site, Seattle

98195

GSK Investigational Site, Seattle

98801

GSK Investigational Site, Wenatchee

331144

GSK Investigational Site, Miami

06902

GSK Investigational Site, Stamford

02747

GSK Investigational Site, North Dartmouth

97504-8456

GSK Investigational Site, Medford

19107-2568

GSK Investigational Site, Philadelphia

53209-0996

GSK Investigational Site, Milwaukee

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY